[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370332-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370332-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-subtypes-of-breast-cancer-in-arab-women-distribution-and-prognostic-insights","Molecular Subtypes of Breast Cancer in Arab Women - Distribution and Prognostic Insights","","Hospital-based cohort evidence characterizes molecular breast cancer subtypes and links them to survival in Arab women. Invasive cases from 1,035 Saudi patients were followed for 12 years at King Faisal Specialist Hospital & Research Center, with tumors classified into luminal A, luminal B, HER2-enriched, and triple-negative. Kaplan–Meier and Cox models show significant subtype-associated differences in survival and mortality, with age, menopause, tumor grade, and advanced stage strongly affecting outcomes. Conclusions emphasize subtype- and stage-driven prognostic risk and the need for tailored care.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-subtypes-of-breast-cancer-in-arab-women-distribution-and-prognostic-insights/370332/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-subtypes-of-breast-cancer-in-arab-women-distribution-and-prognostic-insights/370332.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were molecular subtypes classified in the study?","Question",{"text":63,"@type":64},"Tumors were classified into four molecular subtypes: luminal A, luminal B, HER2-enriched, and triple-negative, based on clinic–pathological data.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which subtypes were most common and how did survival differ?",{"text":68,"@type":64},"Luminal A was the most common (41.7%) and luminal A and B had the highest 5-year survival rates (~83%). Triple-negative had lower survival (76.4%) with a higher hazard ratio, while HER2-enriched had the lowest (69.1%).",{"name":70,"@type":61,"acceptedAnswer":71},"What factors were associated with mortality?",{"text":72,"@type":64},"Age at diagnosis, menopause, and tumor grade were significantly associated with subtypes, while survival and mortality varied by subtype (p=0.0202). Advanced-stage cancers (III and IV) showed markedly higher mortality risk compared with early-stage disease.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370332,1790217148,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of Epidemiology and Global Health (2025) 15:36  \n[https://doi.org/10.1007/s44197-025-00376-z](https://doi.org/10.1007/s44197-025-00376-z)  \nRESEARCH ARTICLE  \nMolecular Subtypes of Breast Cancer in Arab Women: Distribution and Prognostic Insights  \nNaser Elkum1 · Abdelilah Aboussekhra2 · Mouad Aboussekhra1 · Hanin Aldalham1 · Lama Alshehri1 · Saleh Alessy1 · Taher AL-Tweigeri3 · Ali Saeed Al-Zahrani1  \nReceived: 14 January 2025 / Accepted: 19 February 2025 © The Author(s) 2025  \nAbstract  \nBackground Understanding the ethnic molecular subtype characteristics of breast cancer (BC) in Saudi women is crucial for providing comprehensive prognostic information and optimizing patient outcomes, making it essential to study their distribution and impact on survival.  \nMethods This hospital-based cohort study analyzed clinic–pathological data from 1,035 Saudi women diagnosed with invasive BC and followed for 12 years, at King Faisal Specialist Hospital & Research Center. Cancers were classified into four molecular subtypes: luminalA, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and triple-negative. Survival outcomes were assessed using Kaplan–Meier survival curves and Cox proportional hazard models.  \nResults Luminal A was the most common molecular subtype (41.7%), followed by luminal B (23.4%), triple-negative (19.5%), and HER2-enriched (15.4%) . Age at diagnosis, menopause, and tumor grade were significantly associated with subtypes (p\u003C 0.05) . Survival outcomes varied significantly (p= 0.0202), with luminal A and B showing the highest 5-year survival rates (~ 83%), triple-negative at 76.4%(hazard ratio: 1.55), and HER2-enriched tumors had the lowest at 69.1%, with a 1.75-fold higher risk of death. Advanced-stage cancers (III and IV) were strongly associated with increased mortality, with hazard ratios of 2.5 and 7.6, respectively, compared to early-stage disease.  \nConclusions Molecular subtypes and stage at diagnosis are key predictors of mortality in Saudi women with BC. The poor outcomes for HER2-enriched and TNBC subtypes highlight the need for timely diagnosis and targeted treatments, emphasizing the importance of personalized care and addressing ethnic variations in BC diagnosis.  \nKeywords Breast cancer · Molecular subtypes · Breast cancer survival · Histopathological stage · Cancer epidemiology · Arab women  \n􀀍 Naser Elkum [nelkum@kfshrc.edu.sa](nelkum@kfshrc.edu.sa)[ ](nelkum@kfshrc.edu.sa)Abdelilah Aboussekhra[aboussekhra@kfshrc.edu.sa](aboussekhra@kfshrc.edu.sa)[ ](aboussekhra@kfshrc.edu.sa)MouadAboussekhra[maboussekhra@gmail.com](maboussekhra@gmail.com)[ ](maboussekhra@gmail.com)HaninAldalham [haldalham@kfshrc.edu.sa](haldalham@kfshrc.edu.sa)[ ](haldalham@kfshrc.edu.sa)Lama Alshehri [lmalshehri@kfshrc.edu.sa](lmalshehri@kfshrc.edu.sa)[ ](lmalshehri@kfshrc.edu.sa)Saleh Alessy [salessy@kfshrc.edu.sa](salessy@kfshrc.edu.sa)  \nTaher AL-Tweigeri  \n[ttwegieri@kfshrc.edu.sa](ttwegieri@kfshrc.edu.sa)  \nAli Saeed Al-Zahrani  \n[alisaz@kfshrc.edu.sa](alisaz@kfshrc.edu.sa)  \n1 Research and Innovation, GCC Cancer Control and Prevention, King Faisal Specialist Hospital and Research Center, PO BOX 3354, Riyadh, KSA 11211, Saudi Arabia  \n2 Cancer Biology and Experimental Therapeutics Section, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, KSA, Saudi Arabia  \n3 Breast Cancer, Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, KSA, Saudi Arabia  \n1 3  \n1 Introduction  \nBreast cancer (BC) is the most common malignancy and a leading cause of cancer-related deaths among women globally [1] . In the Kingdom of Saudi Arabia (KSA), BC is the most prevalent cancer among females [2], with incidence rates on the rise in line with global trends. The annual agestandardized rate of BC in KSAis 28.4 per 100,000 women, indicating a growing burden of the disease. Currently, BC accounts for 31.4% of all diagnosed cancer cases in KSA [3], highlightin","cbCailBEQY5640yM","https://ap.wps.com/l/cbCailBEQY5640yM","pdf",1044260,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"How were molecular subtypes classified in the study?\",\"answer\":\"Tumors were classified into four molecular subtypes: luminal A, luminal B, HER2-enriched, and triple-negative, based on clinic–pathological data.\"},{\"question\":\"Which subtypes were most common and how did survival differ?\",\"answer\":\"Luminal A was the most common (41.7%) and luminal A and B had the highest 5-year survival rates (~83%). Triple-negative had lower survival (76.4%) with a higher hazard ratio, while HER2-enriched had the lowest (69.1%).\"},{\"question\":\"What factors were associated with mortality?\",\"answer\":\"Age at diagnosis, menopause, and tumor grade were significantly associated with subtypes, while survival and mortality varied by subtype (p=0.0202). Advanced-stage cancers (III and IV) showed markedly higher mortality risk compared with early-stage disease.\"}]","Molecular Subtypes of Breast Cancer in Arab Women - Distribution and Prognostic Insights | PDF",1790188070,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37d0dc1ad3c10f0fc2305a4270f5bdc6.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97e29c5588104ca014a9f650033ce254.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b80a94fa281eea11da8817560a65be0a.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd7d41677af680d8a4eadbcc4c792574.webp",980,1301]